Blood and Marrow Transplant Clinical Research Network

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Collaborator: Blood and Marrow Transplant Clinical Trials Network
• Treatments: Dexamethasone; Fluconazole; Thalidomide; Voriconazole

Criteria

Criteria for entry into a study varies by protocol